Menu Search
Equities

Pa Shun International Holdings Ltd

574:HKG.HZ

Pa Shun International Holdings Ltd

Actions
  • Price (HKD)0.055
  • Today's Change0.007 / 14.58%
  • Shares traded578.00k
  • 1 Year change-11.29%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pa Shun International Holdings Limited, formerly Pa Shun Pharmaceutical International Holdings Limited is a Hong Kong-based investment holding company principally engaged in pharmaceutical businesses. The Company operates through three segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceuticals to wholesalers, pharmacy stores, hospitals and other medical institutions, among others. Self-operated Retail Pharmacies segment is mainly engaged in pharmaceutical and healthcare products, cosmetic products and daily necessities in self-operated retail pharmacies. Pharmaceutical Manufacturing segment is engaged in the sales of pharmaceutical products manufactured by the Company.

  • Revenue in HKD (TTM)139.89m
  • Net income in HKD2.54m
  • Incorporated2011
  • Employees90.00
  • Location
    Pa Shun International Holdings Ltd Hong KongHKG
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.